JACLYN VINAGRE: Open Payments
NPI 1558993386 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 21 payments from 14 companies in 2025. Trend: 2023 $877 · 2024 $163 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $106 |
| ABBVIE INC. | 3 | $63 |
| Botanix SB Inc | 2 | $60 |
| PFIZER INC. | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $41 |
| Almirall LLC | 2 | $40 |
| Organon LLC | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $26 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
Products named: Xeomin, SOFDRA, CIBINQO, TREMFYA, Klisyri, RINVOQ, DUPIXENT, ILUMYA.
Industry payments across NY — which companies pay providers there.
